NASDAQ:TCRR - Nasdaq - US87808K1060 - Common Stock - Currency: USD
TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
Operating Expenses | 131.37M | 122.85M | 96.08M | 68.70M | 51.38M | |||
Research and Development | 105.05M | 98.42M | 73.58M | 51.98M | 37.49M | |||
Selling, General, and Administrative Expenses | 26.32M | 24.44M | 22.50M | 16.72M | 13.89M | |||
Operating Income | -131.37M | -122.85M | -96.08M | -68.70M | -51.38M | |||
Interest Income/Expense | 2.93M | 1.94M | 224.00K | 1.74M | 3.89M | |||
Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
Non Recurring Items | -34.43M | -30.64M | -3.66M | N/A | N/A | |||
Income Before Taxes | -162.87M | -151.56M | -99.52M | -66.96M | -47.50M | |||
Income Tax | 228.00K | 261.00K | 289.00K | 160.00K | 100.00K | |||
Net Income | -163.10M | -151.82M | -99.81M | -67.12M | -97.50M | |||
EBITDA | -128.42M | -119.81M | -93.25M | -67.11M | -50.52M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -4.20 | -3.93 | -2.63 | -2.40 | -4.62 | |||
Non GAAP EPS | -4.20 | -3.93 | -2.63 | -2.43 | -6.43 | |||
Statistics |
All data in USD